ISRCTN22144829CompletedNot Applicable
ipids in Diabetes Study
Bayer PLC (UK)0 sites5,000 target enrollmentStarted: May 31, 2002Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 5,000
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •Established type 2 diabetics aged between 40 and 75
Exclusion Criteria
- •Not provided at time of registration
Investigators
Similar Trials
Recruiting
Not Applicable
Investigation of popular diabetes-asscociated indices: according to the class of glucose tolerancetype 2 diabetesJPRN-UMIN000012913Diabetes and Endocrinology, Kobe university school of medicine103
Completed
Not Applicable
Investigation of popular diabetes -assosiated indices: toward better understanding CPIT2DMJPRN-UMIN000010899Kobe university School of Medicine Division of Diabetes and Endcrinology87
Completed
Not Applicable
Investigation of popular diabetes -associated indices: toward better understanding CPI through OGTT time courseType 2 diabetesJPRN-UMIN000010904Kobe university School of Medicine Division ofDiabetes and Endocrinology87
Not yet recruiting
Phase 1
A research for the clinical validity of Diabetes decoction which was set up by national medical master professor Yan Dexin and was used for treating type 2 diabetes with spleen-deficiency and blood-stasis syndrome in the early periodType 2 diabetesITMCTR1900002699Shanghai Traditional Chinese Medicine Hospital
Recruiting
Not Applicable
Multicenter Investigation for Diabetes mellitus in AtheroSclerosisPatients admitted to the participating institution for 1. Acute myocardial infarction within 24 hours after symptom onset 2. Angina pectoris requiring PCI 3. Heart failure 4. Atrial fibrillation undergoing catheter ablation 5. Cerebral infarction 6. Transient ischemic attackJPRN-UMIN000010039ational Cerebral and Cardiovascular Center5,000